vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and Enovix Corp (ENVX). Click either name above to swap in a different company.
AGIOS PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($20.0M vs $11.3M, roughly 1.8× Enovix Corp). Enovix Corp runs the higher net margin — -310.6% vs -541.1%, a 230.5% gap on every dollar of revenue. On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs 15.9%). Enovix Corp produced more free cash flow last quarter ($-28.0M vs $-97.3M). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs 46.2%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Enovix Corp is an advanced battery technology company that designs, develops and manufactures high-energy-density 3D silicon anode lithium-ion batteries. Its products serve consumer electronics, wearable devices, electric vehicles, and renewable energy storage segments, with customers and operations across North America, Asia and Europe.
AGIO vs ENVX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $11.3M |
| Net Profit | $-108.0M | $-35.0M |
| Gross Margin | 90.6% | 22.2% |
| Operating Margin | -608.9% | -390.5% |
| Net Margin | -541.1% | -310.6% |
| Revenue YoY | 86.1% | 15.9% |
| Net Profit YoY | -11.9% | 6.6% |
| EPS (diluted) | $-1.86 | $-0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.0M | $11.3M | ||
| Q3 25 | $12.9M | $8.0M | ||
| Q2 25 | $12.5M | $7.5M | ||
| Q1 25 | $8.7M | $5.1M | ||
| Q4 24 | $10.7M | $9.7M | ||
| Q3 24 | $9.0M | $4.3M | ||
| Q2 24 | $8.6M | $3.8M | ||
| Q1 24 | $8.2M | $5.3M |
| Q4 25 | $-108.0M | $-35.0M | ||
| Q3 25 | $-103.4M | $-53.7M | ||
| Q2 25 | $-112.0M | $-44.5M | ||
| Q1 25 | $-89.3M | $-23.5M | ||
| Q4 24 | $-96.5M | $-37.5M | ||
| Q3 24 | $947.9M | $-22.5M | ||
| Q2 24 | $-96.1M | $-115.9M | ||
| Q1 24 | $-81.5M | $-46.4M |
| Q4 25 | 90.6% | 22.2% | ||
| Q3 25 | 87.0% | 17.5% | ||
| Q2 25 | 86.3% | 26.0% | ||
| Q1 25 | 87.6% | 5.1% | ||
| Q4 24 | 88.3% | 10.8% | ||
| Q3 24 | 91.3% | -14.9% | ||
| Q2 24 | 82.6% | -17.4% | ||
| Q1 24 | 92.3% | -34.1% |
| Q4 25 | -608.9% | -390.5% | ||
| Q3 25 | -907.4% | -587.9% | ||
| Q2 25 | -1020.1% | -585.6% | ||
| Q1 25 | -1222.0% | -834.8% | ||
| Q4 24 | -1165.3% | -355.2% | ||
| Q3 24 | -1146.9% | -1141.2% | ||
| Q2 24 | -1228.3% | -2355.4% | ||
| Q1 24 | -1124.3% | -1330.3% |
| Q4 25 | -541.1% | -310.6% | ||
| Q3 25 | -803.1% | -672.3% | ||
| Q2 25 | -899.4% | -596.3% | ||
| Q1 25 | -1023.3% | -461.2% | ||
| Q4 24 | -899.6% | -385.6% | ||
| Q3 24 | 10574.7% | -522.0% | ||
| Q2 24 | -1115.7% | -3075.2% | ||
| Q1 24 | -995.8% | -879.5% |
| Q4 25 | $-1.86 | $-0.14 | ||
| Q3 25 | $-1.78 | $-0.27 | ||
| Q2 25 | $-1.93 | $-0.22 | ||
| Q1 25 | $-1.55 | $-0.12 | ||
| Q4 24 | $-1.44 | $0.00 | ||
| Q3 24 | $16.22 | $-0.28 | ||
| Q2 24 | $-1.69 | $-0.63 | ||
| Q1 24 | $-1.45 | $-0.28 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | $512.0M |
| Total DebtLower is stronger | — | $519.5M |
| Stockholders' EquityBook value | $1.2B | $271.2M |
| Total Assets | $1.3B | $879.0M |
| Debt / EquityLower = less leverage | — | 1.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.1M | $512.0M | ||
| Q3 25 | $92.7M | $558.8M | ||
| Q2 25 | $80.9M | $203.4M | ||
| Q1 25 | $79.0M | $248.2M | ||
| Q4 24 | $76.2M | $272.9M | ||
| Q3 24 | $253.7M | $200.9M | ||
| Q2 24 | $84.5M | $249.9M | ||
| Q1 24 | $118.8M | $262.4M |
| Q4 25 | — | $519.5M | ||
| Q3 25 | — | $518.6M | ||
| Q2 25 | — | $169.7M | ||
| Q1 25 | — | $169.4M | ||
| Q4 24 | — | $170.0M | ||
| Q3 24 | — | $168.9M | ||
| Q2 24 | — | $170.1M | ||
| Q1 24 | — | $169.8M |
| Q4 25 | $1.2B | $271.2M | ||
| Q3 25 | $1.3B | $294.3M | ||
| Q2 25 | $1.4B | $203.7M | ||
| Q1 25 | $1.5B | $235.1M | ||
| Q4 24 | $1.5B | $246.7M | ||
| Q3 24 | $1.6B | $167.6M | ||
| Q2 24 | $660.5M | $170.3M | ||
| Q1 24 | $743.9M | $229.3M |
| Q4 25 | $1.3B | $879.0M | ||
| Q3 25 | $1.4B | $913.7M | ||
| Q2 25 | $1.5B | $469.1M | ||
| Q1 25 | $1.6B | $499.0M | ||
| Q4 24 | $1.7B | $527.2M | ||
| Q3 24 | $1.8B | $448.0M | ||
| Q2 24 | $773.1M | $489.0M | ||
| Q1 24 | $849.7M | $508.9M |
| Q4 25 | — | 1.92× | ||
| Q3 25 | — | 1.76× | ||
| Q2 25 | — | 0.83× | ||
| Q1 25 | — | 0.72× | ||
| Q4 24 | — | 0.69× | ||
| Q3 24 | — | 1.01× | ||
| Q2 24 | — | 1.00× | ||
| Q1 24 | — | 0.74× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | $-27.0M |
| Free Cash FlowOCF − Capex | $-97.3M | $-28.0M |
| FCF MarginFCF / Revenue | -487.5% | -248.6% |
| Capex IntensityCapex / Revenue | 5.6% | 8.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | $-113.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.2M | $-27.0M | ||
| Q3 25 | $-88.2M | $-25.5M | ||
| Q2 25 | $-77.1M | $-25.9M | ||
| Q1 25 | $-111.5M | $-16.9M | ||
| Q4 24 | $-133.2M | $-16.0M | ||
| Q3 24 | $-84.2M | $-30.7M | ||
| Q2 24 | $-72.6M | $-26.9M | ||
| Q1 24 | $-99.9M | $-35.0M |
| Q4 25 | $-97.3M | $-28.0M | ||
| Q3 25 | $-89.7M | $-28.5M | ||
| Q2 25 | $-78.0M | $-33.8M | ||
| Q1 25 | $-112.3M | $-23.2M | ||
| Q4 24 | $-134.1M | $-32.3M | ||
| Q3 24 | $-84.6M | $-50.2M | ||
| Q2 24 | $-72.7M | $-52.2M | ||
| Q1 24 | $-100.0M | $-50.1M |
| Q4 25 | -487.5% | -248.6% | ||
| Q3 25 | -696.5% | -356.7% | ||
| Q2 25 | -626.2% | -453.0% | ||
| Q1 25 | -1286.4% | -454.7% | ||
| Q4 24 | -1250.1% | -332.6% | ||
| Q3 24 | -944.2% | -1163.2% | ||
| Q2 24 | -844.4% | -1384.2% | ||
| Q1 24 | -1221.2% | -950.9% |
| Q4 25 | 5.6% | 8.9% | ||
| Q3 25 | 12.1% | 37.2% | ||
| Q2 25 | 7.0% | 106.7% | ||
| Q1 25 | 8.8% | 123.0% | ||
| Q4 24 | 9.0% | 168.3% | ||
| Q3 24 | 4.7% | 452.5% | ||
| Q2 24 | 1.8% | 669.0% | ||
| Q1 24 | 1.7% | 286.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.09× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
